GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion AG (FRA:PA8) » Definitions » Additional Paid-In Capital

Paion AG (FRA:PA8) Additional Paid-In Capital : €208.75 Mil(As of Jun. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Paion AG Additional Paid-In Capital?


Paion AG's quarterly additional paid-in capital increased from Jun. 2022 (€144.50 Mil) to Dec. 2022 (€144.54 Mil) and increased from Dec. 2022 (€144.54 Mil) to Jun. 2023 (€208.75 Mil).

Paion AG's annual additional paid-in capital increased from Dec. 2020 (€141.91 Mil) to Dec. 2021 (€144.41 Mil) and increased from Dec. 2021 (€144.41 Mil) to Dec. 2022 (€144.54 Mil).

Paion AG Additional Paid-In Capital Historical Data

The historical data trend for Paion AG's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paion AG Additional Paid-In Capital Chart

Paion AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 138.73 139.42 141.91 144.41 144.54

Paion AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 144.23 144.41 144.50 144.54 208.75

Paion AG Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Paion AG Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Paion AG's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Paion AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion AG (FRA:PA8) » Definitions » Additional Paid-In Capital
Comparable Companies
FRA:Z61 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XTAE:TEVA XSWX:SDZ NBIX NSE:DIVISLAB BOM:532321 VTRS BOM:500124 NSE:TORNTPHARM HKSE:03692 SZSE:000538 TSE:4507 TSE:4523 BOM:500257
Traded in Other Exchanges
PAIOF:USA PA8:Germany
Address
Heussstrasse 25, Aachen, DEU, 52078
Website
https://www.paion.com
Paion AG is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.

Paion AG Headlines

No Headlines